Skip to content

Clinical trials

Metabolism, Inborn Errors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Country / region: United States Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20043
20052
20063
20073
20085
20095
20112
20121
20133
20142
20153
20162
20171
20182
20192
20201
20217
20224
20232
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting12
Terminated11
Unknown status7
Active, not recruiting3
Withdrawn2
No longer available1
Not yet recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)14
ModernaTX, Inc.5
National Human Genome Research Institute (NHGRI)5
Kastle Therapeutics, LLC3
Masonic Cancer Center, University of Minnesota3
Regeneron Pharmaceuticals3
Alexion Pharmaceuticals, Inc.2
Children's Hospital of Philadelphia2
Duke University2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors85
Genetic Diseases, Inborn34
Metabolic Diseases30
Rare Diseases19
Lysosomal Storage Diseases15
Sphingolipidoses11
Lipid Metabolism Disorders9
Mucopolysaccharidosis I9
Brain Diseases, Metabolic, Inborn8
Gaucher Disease8

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.